Skip to content

Clarivate CLVT A&G — Goodwill impairment

Other segment segments

Life Sciences & Healthcare
$149.1M+156%
IP
$13.8M

Similar metrics at other companies

General Mills logo
GISInternational — Goodwill impairment
$0
ON Semiconductor logo
ONAMG — Accumulated goodwill impairment loss
$748.9M
Bausch Health Companies logo
BHCGoodwill impairments
$1.43B
Fox Factory Holding Corp. logo
FOXFAAG — Impairment of intangible assets
$1.26M
Driven Brands Holdings Inc. logo
DRVNGoodwill impairment
$7.08M
Lakeland Industries logo
LAKEGoodwill Impairments
$651K-75.3%

Other financials

Income statement

See full
Revenue$587.3M-5.5%
Gross profit$401.8M-3.8%
Operating income-$200.2M-3,001%
Net income-$268.6M-273%
EPS (diluted)-$0.42-282%

Balance sheet

See full
Cash & equivalents$217.7M-40.0%
Total debt$4.3B-7.4%
Total equity$4.5B-9.1%
Total assets$10.5B-8.2%

Cash flow

See full
Operating cash flow$98.7M-15.1%
CapEx$54.7M-17.1%
Free cash flow$44.0M-12.5%

Valuation

See full
Market cap$1.36B-46.9%
Enterprise value$5.47B-21.6%
P/S0.6×-0.5×

Profitability

See full
Gross margin66.8%+0.8pp
Operating margin-3.5%+5.5pp
Net margin-14%-2.3pp
FCF margin13.6%-0.3pp

Returns & leverage

See full
Return on equity-7.1%-0.8pp
Debt / equity0.0×
Current ratio0.8×-0.1×

Where this comes from

Reported directly by Clarivate in its filing.

Tagged under the XBRL concept us-gaap:GoodwillImpairmentLoss.

The official record: Clarivate’s 10-K, filed February 19, 2025, on SEC EDGAR. View the filing →

Ask your AI about Clarivate's a&g — goodwill impairment.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Clarivate's A&G — goodwill impairment?
Clarivate (CLVT) reported A&G — goodwill impairment of $0 in Q4 2024.
What does A&G — goodwill impairment mean?
Measures the non-cash charge recognized when the carrying value of goodwill associated with the Academia and Government segment exceeds its implied fair value. This serves as a critical indicator of potential overpayment for past acquisitions or a decline in the long-term economic prospects of the segment's business units.